Basics ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. IPO Date: July 18, 2013 Sector: Healthcare Industry: Pharma Market Cap: $1.34B Activated in VL: True Average Daily Range Avg Daily Range: $0.91 | 2.07% Avg Daily Range (30 D): $1.23 | 1.87% Avg Daily Range (90 D): $1.11 | 1.75% Institutional Daily Volume Avg Daily Volume: .14M Avg Daily Volume (30 D): .34M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 45 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 2,002 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $2.59M Avg Inst. Trade (90 D): $2.72M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.11M Avg Closing Trade (30 D): $3.1M Avg Closing Trade (90 D): $3.32M Avg Closing Volume: 37.4K     News May 12, 2025 @ 10:30 PM ANI Pharmaceuticals to Participate at the H.C. Wai... Source: N/A Feb 28, 2025 @ 3:37 PM ANI Pharmaceuticals Expects Strong Start To 2025, ... Source: Vandana Singh Oct 30, 2024 @ 9:00 PM ANI Pharmaceuticals to Discuss Third Quarter 2024 ... Source: N/A Oct 18, 2024 @ 6:38 PM Avadel Obtains FDA Nod for Label Expansion Of Narc... Source: Zacks Oct 17, 2024 @ 5:44 PM Alnylam Stock Up on Cardiomyopathy Drug Regulatory... Source: Zacks Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.26 $.7 $-.55 Diluted EPS $-1.27 $.69 $-.55 Revenue $ 674.07M $ 197.12M $ 190.57M Gross Profit $ $ $ Net Income / Loss $ -21.05M $ 15.68M $ -10.28M Operating Income / Loss $ 6.47M $ 26.19M $ -4.38M Cost of Revenue $ $ $ Net Cash Flow $ -78.76M $ 4.94M $ -.12M PE Ratio     Splits Jul 18, 2013:   1:6 Jun 04, 2012:   1:6 Jun 03, 2002:   1:10